GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Haoyuan Chemexpress Co Ltd (SHSE:688131) » Definitions » Other Operating Expense

Shanghai Haoyuan Chemexpress Co (SHSE:688131) Other Operating Expense : ¥263 Mil (TTM As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai Haoyuan Chemexpress Co Other Operating Expense?

Shanghai Haoyuan Chemexpress Co's Other Operating Expense for the three months ended in Mar. 2025 was ¥-2 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥263 Mil.

Shanghai Haoyuan Chemexpress Co's quarterly Other Operating Expense increased from Sep. 2024 (¥-144 Mil) to Dec. 2024 (¥274 Mil) but then declined from Dec. 2024 (¥274 Mil) to Mar. 2025 (¥-2 Mil).

Shanghai Haoyuan Chemexpress Co's annual Other Operating Expense increased from Dec. 2022 (¥168 Mil) to Dec. 2023 (¥245 Mil) and increased from Dec. 2023 (¥245 Mil) to Dec. 2024 (¥264 Mil).


Shanghai Haoyuan Chemexpress Co Other Operating Expense Historical Data

The historical data trend for Shanghai Haoyuan Chemexpress Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haoyuan Chemexpress Co Other Operating Expense Chart

Shanghai Haoyuan Chemexpress Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 62.93 107.19 167.90 245.47 264.31

Shanghai Haoyuan Chemexpress Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.43 135.22 -143.68 274.19 -2.34

Shanghai Haoyuan Chemexpress Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥263 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Haoyuan Chemexpress Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Shanghai Haoyuan Chemexpress Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Haoyuan Chemexpress Co Business Description

Traded in Other Exchanges
N/A
Address
No. 2, Lane 720, Cailun Road, Room 501, Pilot Free Trade Zone, Shanghai, CHN, 201203
Shanghai Haoyuan Chemexpress Co Ltd focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. The company's comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. It is a one-stop service platform to support client's projects from early drug discovery, process development to commercialization. The company is committed to delivering high-quality products and CMC services to clients across the entire life cycle of drug development.
Executives
Mei Kui Core technical personnel

Shanghai Haoyuan Chemexpress Co Headlines

No Headlines